ABSTRACT
Multiple sclerosis (MS) has protean manifestations, and the care of people with MS presents many unique challenges. Clinicians can have an important impact on health, quality of life, and daily functioning by participating in open dialogue, tailoring focused treatment plans, and anticipating general medical needs.
Footnotes
↵* Dr. Fox has indicated that he has served as a cosultant for the Acorda Therapeutics, Biogen Idec, Genetech, Merck, Questcor, Serono, and Teva Neuroscience corporations and on the speaker’s bureaus of the Biogen Idec and Genentech corporations.
↵† Dr. Bethoux has indicated that he has received research funding from and served on the speakers bureau of the Medtronic corporation.
- © 2006 The Cleveland Clinic Foundation. All Rights Reserved.
View Abstract
